The opening of Merck’s healthcare research and development centre in Bengaluru was announced on Thursday.
The Merck India R&D Excellence Centre helps treat patients with unmet medical needs all around the world by contributing to the company’s healthcare R&D.
About 300 employees are employed in the German pharmaceutical company’s centre, which will keep growing over the next two years.
“Through the Centre, we will increase our involvement in healthcare research and development in India while assisting the Merck Group’s international drug discovery activities. According to Suneela Thatte, vice president and director of the R&D Excellence Centre, the Bangalore centre’s goals are to create a culture of working as a single team, deliver important tasks related to medication development, and build a strong talent base. The statement was reported by ET.
Thatte continued, “The R&D Excellence Centre aspires to unite the finest of local talent and international best practices to enable the vision of increased patient outcomes.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.